The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; MSD; PharmaMar; Roche
Speakers' Bureau - PharmaMar; Roche
Phase II randomized trial of neoadjuvant (NA) chemotherapy (CT) with or without bevacizumab (Bev) in advanced epithelial ovarian cancer (EOC)‏ (GEICO 1205/NOVA TRIAL).
 
Yolanda Garcia Garcia
Speakers' Bureau - Janssen (I); Roche
 
Ana De Juan
No Relationships to Disclose
 
Cesar Mendiola
Speakers' Bureau - Roche
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pharmamar-zeltia; Roche
 
Maria Pilar Barretina-Ginesta
Consulting or Advisory Role - Roche
Speakers' Bureau - AstraZeneca; PharmaMar; Roche
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche
 
Aleix Prat
Consulting or Advisory Role - Novartis
 
Ana Santaballa
Travel, Accommodations, Expenses - Roche
 
Isabel Bover
No Relationships to Disclose
 
Marta Gil-Martin
No Relationships to Disclose
 
Aránzazu Manzano
No Relationships to Disclose
 
M Jesus Rubio
No Relationships to Disclose
 
Margarita Romeo
No Relationships to Disclose
 
Cristina Arqueros
No Relationships to Disclose
 
Elena Garcia Martinez
No Relationships to Disclose
 
Antonio Gonzalez Martin
No Relationships to Disclose